Skip to main content

PerkinElmer to Open New India Facility

NEW YORK (GenomeWeb News) – PerkinElmer said this week that it will open a new Bio-pharma Center of Excellence in Hyderabad, India, later this year.

The center, which is scheduled to open in October, will provide PerkinElmer's clients with screening and profiling technologies, access to drug discovery tools and services and quality control applications, training facilities, and expertise.

The center will enable the company to focus on the drug discovery market in India, and it is part of PerkinElmer's plan to "substantially broaden" its presence in India in certain markets, and to expand "links with government and private research institutes," the company said.

PerkinElmer India's President, Fedja Bobanovic, said in a statement that the company is expanding in the country because it "presents compelling growth opportunities in environmental monitoring, neonatal and maternal screening, and pharmaceutical research."

In 2008 the company opened a Technology and Innovations Facility in Mumbai that focuses on environmental health sciences.

Filed under

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.